1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. CXO Perspective
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. ARTIFICIAL INTELLIGENCE (AI) IN ONCOLOGY MARKET BY COMPONENT TYPE
5.1. Introduction
5.2. Software Solutions
5.3. Hardware
5.4. Services
6. ARTIFICIAL INTELLIGENCE (AI) IN ONCOLOGY MARKET BY CANCER TYPE
6.1. Introduction
6.2. Breast Cancer
6.3. Lung Cancer
6.4. Prostate Cancer
6.5. Colorectal Cancer
6.6. Brain Tumor
6.7. Others
7. ARTIFICIAL INTELLIGENCE (AI) IN ONCOLOGY MARKET BY TREATMENT TYPE
7.1. Introduction
7.2. Chemotherapy
7.3. Radiotherapy
7.4. Immunotherapy
7.5. Others
8. ARTIFICIAL INTELLIGENCE (AI) IN ONCOLOGY MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Component Type
8.2.2. By Cancer Type
8.2.3. By Treatment Type
8.2.4. By Country
8.2.4.1. USA
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Component Type
8.3.2. By Cancer Type
8.3.3. By Treatment Type
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Component Type
8.4.2. By Cancer Type
8.4.3. By Treatment Type
8.4.4. By Country
8.4.4.1. United Kingdom
8.4.4.2. Germany
8.4.4.3. France
8.4.4.4. Spain
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. By Component Type
8.5.2. By Cancer Type
8.5.3. By Treatment Type
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. UAE
8.5.4.3. Israel
8.5.4.4. Others
8.6. Asia Pacific
8.6.1. By Component Type
8.6.2. By Cancer Type
8.6.3. By Treatment Type
8.6.4. By Country
8.6.4.1. Japan
8.6.4.2. China
8.6.4.3. India
8.6.4.4. South Korea
8.6.4.5. Indonesia
8.6.4.6. Thailand
8.6.4.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Azra AI
10.2. IBM
10.3. Siemens Healthcare GmbH
10.4. Intel Corporation
10.5. GE HealthCare
10.6. NVIDIA Corporation
10.7. Digital Diagnostics Inc.
10.8. ConcertAI
10.9. Median Technologies
10.10. PathAI